Similar articles for PMID: 8441024

Year	Number of Results
1955	1
1980	1
1982	2
1983	2
1984	3
1985	5
1986	5
1987	12
1988	5
1989	10
1990	8
1991	17
1992	9
1993	7
1994	3
1995	8
1996	9
1997	5
1998	3
1999	1
2000	2
2001	4
2002	1
2003	1
2006	1
2011	1
2016	1
2022	0

1

Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogeneous tissues: theoretical considerations and practical procedure.

Lucignani G, Schmidt KC, Moresco RM, Striano G, Colombo F, Sokoloff L, Fazio F. Lucignani G, et al. J Nucl Med. 1993 Mar;34(3):360-9. J Nucl Med. 1993. PMID: 8441024 Free article.

2

Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.

Schmidt K, Lucignani G, Moresco RM, Rizzo G, Gilardi MC, Messa C, Colombo F, Fazio F, Sokoloff L. Schmidt K, et al. J Cereb Blood Flow Metab. 1992 Sep;12(5):823-34. doi: 10.1038/jcbfm.1992.114. J Cereb Blood Flow Metab. 1992. PMID: 1506447

3

Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.

Heiss WD, Pawlik G, Herholz K, Wagner R, Göldner H, Wienhard K. Heiss WD, et al. J Cereb Blood Flow Metab. 1984 Jun;4(2):212-23. doi: 10.1038/jcbfm.1984.30. J Cereb Blood Flow Metab. 1984. PMID: 6609929

4

Cerebral glucose metabolic rates after 30 and 45 minute acquisitions: a comparative study.

Kumar A, Braun A, Schapiro M, Grady C, Carson R, Herscovitch P. Kumar A, et al. J Nucl Med. 1992 Dec;33(12):2103-5. J Nucl Med. 1992. PMID: 1460500 Free article.

5

Two behavioral states studied in a single PET/FDG procedure: theory, method, and preliminary results.

Chang JY, Duara R, Barker W, Apicella A, Finn R. Chang JY, et al. J Nucl Med. 1987 May;28(5):852-60. J Nucl Med. 1987. PMID: 3494830 Free article.

6

Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data.

Dhawan V, Moeller JR, Strother SC, Evans AC, Rottenberg DA. Dhawan V, et al. J Nucl Med. 1989 Sep;30(9):1483-8. J Nucl Med. 1989. PMID: 2788721 Free article.

7

Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.

Kuwabara H, Gjedde A. Kuwabara H, et al. J Nucl Med. 1991 Apr;32(4):692-8. J Nucl Med. 1991. PMID: 2013809 Free article.

8

Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.

Piert M, Koeppe RA, Giordani B, Minoshima S, Kuhl DE. Piert M, et al. J Nucl Med. 1996 Jul;37(7):1115-22. J Nucl Med. 1996. PMID: 8965180 Free article.

9

Human cerebral glucose metabolism determined by positron emission tomography: a revisit.

Brooks RA, Hatazawa J, Di Chiro G, Larson SM, Fishbein DS. Brooks RA, et al. J Cereb Blood Flow Metab. 1987 Aug;7(4):427-32. doi: 10.1038/jcbfm.1987.86. J Cereb Blood Flow Metab. 1987. PMID: 3497163

10

Effects of percent thresholding on the extraction of [18F]fluorodeoxyglucose positron emission tomographic region-of-interest data.

Rottenberg DA, Moeller JR, Strother SC, Dhawan V, Sergi ML. Rottenberg DA, et al. J Cereb Blood Flow Metab. 1991 Mar;11(2):A83-8. doi: 10.1038/jcbfm.1991.42. J Cereb Blood Flow Metab. 1991. PMID: 1997493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed